Filing Details

Accession Number:
0000912282-24-000172
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-21 11:55:02
Reporting Period:
2024-02-16
Accepted Time:
2024-02-21 11:55:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509261 Rezolute Inc. RZLT Pharmaceutical Preparations (2834) 273440894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829608 Kenneth Brian Roberts C/O Rezolute, Inc.
275 Shoreline Drive, Suite 500
Redwood City CA 94065
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-02-16 7,000 $1.31 34,552 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.320, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.